4 papers in the library · 54 citations · publishing 2019-2025
JAMA Psychiatry April 9, 2025 Jessica Ahrens, Sabrina D. Ford, Betsy Schaefer et al.
This cohort study investigates the association between cannabis and the midbrain dopamine pathway involved in psychosis.
Schizophrenia Research September 1, 2023 Angelica M Silva, Roberto Limongi, Michael Mackinley et al. 49 citations
In the clinical linguistics of schizophrenia, syntactic complexity has received much attention. In this study, we address whether syntactic complexity deteriorates within the six months following the first episode of psychosis in those who develop a diagnosis of schizophrenia. We collected data from a cohort of twenty-six first-episode psychosis and 12 healthy control subjects using the Thought...
Pilot and Feasibility Studies February 11, 2019 Lindsay S. Nagamatsu, Sabrina D. Ford 5 citations
BACKGROUND: Falls are a major health care concern for our aging population. Previous research has identified impaired sustained attention as a risk factor for falls. Recently, meditation has been shown to improve different types of attention in various populations. However, there are no studies to date examining whether meditation training can improve sustained attention and mobility in older...
Jessica Ahrens, Sabrina D. Ford, Betsy Schaefer et al. preprint
Abstract Importance Despite evidence that individuals who use cannabis early in life are at elevated risk of psychosis and that the neurotransmitter dopamine has a role in both conditions, the mechanism linking the two conditions remains unclear. Objective To use neuromelanin-sensitive MRI (neuromelanin-MRI), a practical, proxy measure of dopamine function, to assess whether a common alteration...